BioSpace News Archive

Neoantigens Market: Developments in Neoantigen Vaccines Against Cancer

The neoantigens market was valued at US$ 2,71,428.57 thousand in 2023, and it is projected to reach US$ 10,54,783.54 thousand by 2028; it is expected to grow at a CAGR of 31.2% from 2023 to 2028.

July 12, 2021
·
5 min read
Pharm Country

Navigating Biotech Risks from Discovery to Approval

Up and down the development pipeline, there are vulnerabilities. From shareholder expectations and IP protection to clinical trial risk and cyberattacks, it’s a minefield and enlisting a risk management partner is vital.

July 12, 2021
·
8 min read
·
Heather McKenzie
Business

Evidence Building for a Mix and Match Approach to COVID-19 Vaccines

Morgan had determined that adding one dose of the Moderna or Pfizer-BioNTech mRNA vaccine to one of Oxford-AstraZeneca’s viral vector technology would equal stronger immunity.

July 12, 2021
·
5 min read
·
Heather McKenzie
Policy

Experts Push Back on Pfizer Claim That COVID-19 Booster is Necessary Now

HHS issued their announcement, saying, “Americans who have been fully vaccinated do not need a booster shot at this time.”

July 12, 2021
·
3 min read
·
Mark Terry
FDA

FDA Gives Enochian Positive Signal on Hijack RNA Treatment for HBV

The company said that it values the FDA’s feedback and is happy that the agency has accepted its request to provide insights on its Hepatitis B development program.

July 12, 2021
·
2 min read
·
Vanessa Doctor, RN
Business

Novo Nordisk Takes Over Prothena’s ATTR Amyloidosis Business for $1.2 Billion

Novo Nordisk will take over Prothena’s wholly-owned subsidiary and gain full global intellectual property rights and other related rights for the latter’s ATTR amyloidosis business and pipeline.

July 12, 2021
·
2 min read
·
Vanessa Doctor, RN
Viral Antigens Market: Increased Acceptance of Viral Antigens in Vaccine Development Fuels Market Growth

The Viral Antigens market was valued at US$101.41 million in 2019 and is projected to reach US$ 236.80 million by 2027; it is expected to grow at a CAGR of 11.0% during 2020–2027.

July 12, 2021
·
4 min read
Hospital Mobile X-Ray Market: Increasing prevalence of chronic conditions drives the adoption of hospital mobile X-ray systems

The hospital mobile X-Ray market was valued at US$ 1,604.92 million in 2019 and it is projected to reach US$ 3,479.79 million by 2027; it is expected to grow at a CAGR of 10.2% during 2020–2027.

July 12, 2021
·
4 min read
Drug Development

Galapagos Touts Positive Post-Hoc Data, but Likely Won’t Gun for US Approval

While the drug showed significant improvement in patients on a 200mg daily dose of filgotinib, it may not be promoted in the states any time soon.

July 12, 2021
·
2 min read
·
Kate Goodwin
Policy

Activist Investors Seek to Steer Control of Phoenixus Away from Jailed “Pharma Bro”

A former CEO of Vyera and other activist investors are pushing a slate of new company directors who would steer control of Phoenixus and Vyera away from Shkreli.

July 12, 2021
·
2 min read
·
Alex Keown